A performance status scale for head and neck cancer patients

List, Marcy A.; Ritter-Sterr, Chris; Lansky, Shirley B.

doi:10.1002/1097-0142(19900801)66:3<564::aid-cncr2820660326>3.0.co;2-d

Cited by 483 publications

(362 citation statements)

References 13 publications

Supporting

Mentioning

357

Contrasting

Unclassified

Order By: Relevance

“…[22,23,27,34,40,42,51,69], using at least one of the following standardized quality-of-life questionnaires: the University of Washington Quality of life questionnaire (UWQol) [85], the Functional Assessment of Cancer Therapy-General (FACT-G) [86], the Functional Assessment of Cancer Therapy-Head and Neck questionnaire (FACT-HN) [86,87], the Quality of Life Questionnaire C-30 (QLQ-C30) [88][89][90], the Quality of Life Questionnaire-Head and Neck 35 (QLQ-HN35) [30,91,92], the European Organisation for Research and Treatment of Cancer (EORTC/RTOG) [85,93,94], and the Performance Status Scale for Head and Neck Cancer Patients (PSS-HN) [95,96]. Most of the studies reported signiWcant improvement for most questionnaire scales over time.…”

Section: Crt and Quality Of Lifementioning

confidence: 99%

Functional outcomes and rehabilitation strategies in patients treated with chemoradiotherapy for advanced head and neck cancer: a systematic review

Molen

Rossum

Burkhead

et al. 2008

Eur Arch Otorhinolaryngol

110

View full text Add to dashboard Cite

Organ preservation with radiotherapy and concomitant chemotherapy has become an accepted treatment modality in advanced head and neck cancer. Unfortunately, organ preservation is not synonymous with function preservation. The aim of this review was to systematically assess the eVects of the disease and chemoradiotherapy (CRT) on functions such as swallowing, mouth opening, nutrition, pain and quality of life in patients with head and neck cancer. Another aim was to search for (evidence-based) techniques or strategies known to alleviate or rehabilitate the loss of function(s) associated with CRT. Two databases were searched (time period, January 1997 to August 2007) for the terms head and neck cancer, chemotherapy or cisplatin and radiotherapy, and the functional outcomes swallowing, trismus, nutrition, pain and quality of life or a variation of those words. In total, 15 relevant articles were identiWed that met the inclusion criteria. The majority of the studies that met the criteria focused on the outcomes swallowing, quality of life, and nutrition. Two studies reported on the outcome pain, but no paper reported on the outcome trismus. Only two papers mentioned rehabilitation options, but speciWc information was lacking. Further long-term prospective research is essential, not only to determine the function impairment caused by the tumor and CRT, but also to assess the eVects of known and newly developed rehabilitation measures. Therefore, in September 2006, the Netherlands Cancer Institute started a randomised clinical trial (RCT): Prevention of trismus, swallowing and speech problems in patients treated with chemoradiotherapy for advanced head and neck cancer. This systematic review was carried out to collect the baseline information for the future outcomes of this RCT.

show abstract

Section: Crt and Quality Of Lifementioning

confidence: 99%

Functional outcomes and rehabilitation strategies in patients treated with chemoradiotherapy for advanced head and neck cancer: a systematic review

Molen

Rossum

Burkhead

et al. 2008

Eur Arch Otorhinolaryngol

110

View full text Add to dashboard Cite

show abstract

“…Prospective quality of life (QOL) assessment included the following well-validated instruments: the Functional Assessment of Cancer Therapy -Head and Neck Version (FACT-H&N) [15,16], the Performance Status Scale for Head and Neck Cancer (PSS-HN) [17,18], and selected items from the McMaster Radiotherapy Questionnaire [19], which assesses patients' perceptions of treatment-related side effects [20,21]. Patients were assessed pretreatment, during treatment, and at 3 months posttreatment.…”

Section: Methodsmentioning

confidence: 99%

Tissue/dose compensation to reduce toxicity from combined radiation and chemotherapy for advanced head and neck cancers

et al. 2001

Self Cite

View full text Add to dashboard Cite

SUMMARY This study was undertaken to quantify the reduction in normal tissuecomplications resulting from the aggressive management of advanced head and neck cancers (AHNCs) utilizing tissue/dose compensation (TDC). Thirty-nine patients with AHNC were treated on an intensive chemotherapy ؉ radiation regimen. Eighteen of 39 patients were treated using TDC; the remaining 21 patients were radiated without TDC (NTDC). Acute and chronic toxicities, swallowing, speech function, and quality of life were assessed. The TDC group had a smaller radiation dose gradient across the entire treatment volume. Unscheduled treatment breaks were required in 11% of TDC patients as compared with 43% of the NTDC group (P ‫؍‬ 0.04). The TDC group had fewer Grade 3 or 4 acute and chronic toxicities and lower SOMA scores. At 3 months posttreatment, patients in the TDC group had better oral intake, lower pharyngeal residue, and better oropharyngeal swallowing efficiency and were able to swallow more bolus types. Patients in the TDC group also had better articulation. Use of TDC resulted in reduced treatmentrelated interruptions, decreased acute and chronic toxicities, and better speech and swallowing functions. Techniques to improve radiation dose conformality around the target tissues while decreasing the radiation dose to the normal tissues should be an integral part of aggressive combined modality therapy.

show abstract

“…9 There are at least 14 validated head and neck questionnaires and most workers in this field recognise that there is no one instrument ideal for all purposes. 10,11 Questionnaires commonly used in the UK include the European Organization for Research and Treatment of Cancer (EORTC), 12 the Functional Assessment of Chronic Illness Therapy (FACIT), 13 and the University of Washington Head and Neck Cancer (UW-QOL) 14 version 4. The purpose of this study was to identify the HRQOL questionnaires employed by the physicians and surgeons who manage patients with head and neck cancer.…”

mentioning

confidence: 99%

A national survey of health-related quality of life questionnaires in head and neck oncology

Kanatas¹,

Rogers²

2004

Ann R Coll Surg Engl

View full text Add to dashboard Cite

A performance status scale for head and neck cancer patients

Cited by 483 publications

References 13 publications

Functional outcomes and rehabilitation strategies in patients treated with chemoradiotherapy for advanced head and neck cancer: a systematic review

Functional outcomes and rehabilitation strategies in patients treated with chemoradiotherapy for advanced head and neck cancer: a systematic review

Tissue/dose compensation to reduce toxicity from combined radiation and chemotherapy for advanced head and neck cancers

A national survey of health-related quality of life questionnaires in head and neck oncology

Contact Info

Product

Resources

About